Study of the Trifunctional Antibody FBTA05 and Donor Lymphocyte Infusion in B-cell Lymphoma After Allogeneic Stem Cell Transplantation (STP-LYM-01)

This study has been terminated.
(Recruitment delayed, trial medication no loner available)
Sponsor:
Information provided by (Responsible Party):
Technische Universität München
ClinicalTrials.gov Identifier:
NCT01138579
First received: June 4, 2010
Last updated: December 2, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: April 2016
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)
No publications provided by Technische Universität München

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):